The Department of Defense's Defense Health Agency awarded a $598,130 Project Grant to Cedars-Sinai Medical Center on February 15, 2025 under the Military Medical Research and Development program (CFDA 12.420). This 2-year grant supports research to investigate the determinants of lung cancer-associated cachexia. Cedars-Sinai, a nonprofit hospital and academic medical center, will conduct this biomedical research project aimed at improving health outcomes for military service members, veterans, and the broader public. The award allows Cedars-Sinai to leverage its expertise in areas like cancer research, clinical trials, biomarker discovery, and data analytics to advance understanding and treatment of this debilitating condition. As a prime recipient, Cedars-Sinai has a history of providing specialized biomedical research services to federal agencies through grants and contracts.
Generated 3/4/25, 7:21 AM